Outer Biosciences sasa inalisha ngozi hai ya binadamu—iliyokusanywa kutoka kwa tishu za upasuaji zilizotupwa na kuwekwa hai kwa zaidi ya mwezi mmoja—kwenye mifumo ya kujifunza kwa mashine (machine-learning). Kampuni hiyo mpya inatumai kufanya ugunduzi wa dawa na utabiri wa dermatolojia kuwa ya kuaminika zaidi. Mchakato wake wa miaka miwili unahamisha tishu kutoka vyumba vya upasuaji kwenda maabarani ndani ya saa chache, kasi ambayo kampuni inasema inahifadhi tabia asilia ya seli.

Kwa nini seti za data za zamani zinashindwa

Kwa sehemu kubwa ya historia ya hivi karibuni ya bioteknolojia, watafiti wamekuwa wakitegemea mifano ya wanyama au mistari ya seli iliyokuzwa (cultured cell lines) ili kufundisha zana za kicompyuta. Mifumo hiyo ni rahisi na bei nafuu, lakini mara chache inakamata utata kamili wa ngozi ya binadamu—kiungo chenye tabaka zenye seli za kinga, ncha za neva, mwingiliano wa microbiome, na mwitikio wa haraka kwa homoni na msongo wa mawazo. Kutofautiana huku kunawalazimu watengenezaji wa dawa kufanya mizunguko mingi ya majaribio ya wanyama na majaribio ya binadamu, jambo linaloongeza gharama na kurefusha muda.

Outer Biosciences inajiweka kama daraja la kuziba pengo hilo. Kwa kutumia tishu ambazo hazijawahi kubadilishwa kwenye chombo cha maabara, kampuni inaamini kuwa AI yake inaweza kujifunza mifumo ambayo haionekani kwenye mifano ya bandia. “Living data” ndiyo msemo ambao timu inautumia kuelezea tofauti kati ya picha tuli ya mstari wa seli na kipande cha tishu kinachoingiliana mfululizo na bado kinawasiliana na mazingira yake.

Kutoka chumba cha upasuaji hadi kwenye algoriti

Changamoto ya kimantiki inalingana na ile ya kisayansi. Outer Biosciences inatafuta ngozi ambayo vinginevyo ingetupwa wakati wa taratibu kama vile abdominoplastia au mastectomia. Benki za bio (biobanks) zisizo za kifaida na za kibiashara, zinazofanya kazi chini ya uangalizi wa Bodi ya Mapitio ya Kitaasisi (IRB), zinarekodi ridhaa ya mchangiaji kwa ajili ya matumizi ya utafiti. Mara tu hospitali inapobainisha sampuli inayofaa, mtandao wa kusafirisha wa kampuni unachukua, unaisafirisha katika vyombo vinavyodhibiti joto, na kuifikisha kwenye kituo cha usindikaji ndani ya saa chache.

Katika maabara, ngozi hiyo inakaa kwenye mfumo wa perfusion unaoiga mtiririko wa damu, na kuweka seli hai kwa hadi siku 30. Katika kipindi hicho, timu inakamata picha za hali ya juu (high-resolution imaging), data za transcriptomics na proteomics katika nyakati mbalimbali. Seti hiyo ya data ya aina mbalimbali (multi-modal dataset) inalisha mifumo ya kujifunza kwa kina (deep-learning pipelines) inayotabiri jinsi tishu itakavyoitikia kwa misombo ya kemikali, mionzi ya UV, au vichocheo vya uvimbe.

Watu wanaoziongoza

Mwanzilishi mwenza na Mkurugenzi Mtendaji Michael Polansky analeta taaluma ya hisabati kutoka Harvard na rekodi ya kukuza shughuli tata, kuanzia mifuko ya uwekezaji (venture-capital) hadi maturubai ya tamasha za kimataifa. Mwanasayansi Mkuu Kyung-Jin Jang, mtaalamu wa biolojia ya ngozi, anaongoza upande wa majaribio, wakati CTO Chris Hinojosa anajenga jukwaa la uhandisi wa data linalounganisha mtiririko wa picha na molekuli. Bodi inajumuisha mwanamuziki maarufu Lady Gaga, ambaye pia anafanya kazi kama mwenyekiti wa chapa ya vipodozi ya Haus Labs, mradi unaoshiriki rasilimali za utafiti na Outer Biosciences.

Uhusiano huu wa viwanda mbalimbali unatoa kwa kampuni hiyo mpya mtaji wa kujenga mtandao wa kipekee wa usafirishaji na soko lililo tayari kwa matumizi ya awali. Haus Labs, kwa mfano, inaweza kujaribu fomula mpya kwenye jukwaa la tishu hai kabla ya kuhamia kwa watu binafsi, jambo linaloweza kupunguza wiki kadhaa katika mzunguko wa kawaida wa maendeleo ya bidhaa.

Nini kiko hatarini

Ikiwa mbinu hii itatimiza ahadi yake, makampuni ya dawa yanaweza kupunguza idadi ya tafiti za wanyama zinazohitajika kwa ajili ya uchunguzi wa hatua za awali, hivyo kupunguza gharama na masuala ya kimaadili. Kliniki za dermatolojia zinaweza kupata zana za AI zinazotabiri jinsi ngozi ya mgonjwa itakavyoitikia kwa krimu ya dawa, jambo linalowezesha mipango ya matibabu ya kibinafsi zaidi. Jumuiya pana ya AI pia inaweza kufaidika na seti ya mafunzo iliyo tajiri zaidi na halisi zaidi inayovunja mipaka ya biolojia ya utabiri.

Mfumo huu unazua maswali kuhusu uwezo wa kutanuka (scalability) na faragha. Kukusanya tishu kutoka kwa upasuaji kunategemea hospitali na wachangiaji walio tayari kushiriki, na mnyororo wa ugavi unaweza kukwama kadiri mahitaji yanavyoongezeka. Ingawa benki za bio hufanya kazi chini ya uangalizi wa IRB, wasifu wa kina wa molekuli unaweza, kinadharia, kuhusishwa na watu binafsi ikiwa taratibu za kushughulikia data zitashindwa. Wakosoaji wanahoji kuwa hata kwa ridhaa, unyonyaji wa kibiashara wa tishu zilizotupwa unavuka mstari mwembamba wa kimaadili.

Hoja kinyume: Je, organoids bado zina nafasi?

Scientists who develop organoids—three-dimensional clusters of cells grown in the lab to mimic organ function—caution against discarding those models entirely. Organoids can be generated from a single patient’s induced pluripotent stem cells, offering a personalized platform without the need for fresh surgical tissue. They also let researchers study developmental processes over months, something a 30-day skin slice cannot do. Outer Biosciences acknowledges that its platform is not a universal replacement but a complementary source of high-fidelity data for specific questions where the native architecture of skin matters most.

The road ahead

Outer Biosciences is currently running pilot studies with several biotech partners, testing the predictive power of its models against known drug outcomes. Early results, shared only in internal briefings, suggest a higher correlation with clinical-trial data than comparable organoid-based predictions. The company plans to expand its tissue collection to include other organ types, though each will bring its own logistical hurdles.

Regulators have not yet issued specific guidance on AI models trained on live human tissue, but the FDA’s emerging framework for AI-driven medical devices will likely intersect with Outer’s work. The startup says it is preparing documentation that meets both data-privacy standards and the agency’s expectations for algorithmic transparency.

Bottom line

Outer Biosciences has turned a logistical feat—moving fresh human skin from the operating room to a lab in a matter of hours—into a data engine that could make AI predictions about drugs and skin health more trustworthy. The venture’s success will hinge on its ability to keep the tissue pipeline flowing, protect donor privacy, and prove that “living data” actually outperforms existing synthetic models. If it does, the ripple effect could be felt across pharma, cosmetics and clinical dermatology, reshaping how we train machines to understand the human body.